IL6 and type 2 diabetes mellitus: Chronic inflammation was said to be improved through the decrease in pro-inflammatory chemokine and cytokine production and this study reported that T2DM patients who received δTE treatment showed a substantial reduction in chronic inflammation as seen by a drop in serum TNF-α, high sensitivity C-reactive protein (hs-CRP) and IL-6 levels [45].